Rosacea Clinical Subtypes and Medical Therapy
On this page
Direct answer
Rosacea is a chronic inflammatory disorder of the central face that presents in four classic subtypes: erythematotelangiectatic, papulopustular, phymatous and ocular. Each subtype has a dominant feature and therefore a different treatment, with papulopustular disease responding to topical metronidazole, azelaic acid or ivermectin. Sub-antimicrobial doxycycline is an established oral option, and because rosacea is often mistaken for acne or eczema, topical steroids must be avoided.
What you must remember
- Core features: centrofacial flushing, persistent erythema, telangiectasia, papules and pustules without comedones, and in some patients phymatous thickening.
- Erythematotelangiectatic subtype: persistent redness with visible vessels; brimonidine or oxymetazoline gel targets the erythema and pulsed-dye laser or intense pulsed light treats vessels.
- Papulopustular subtype: inflammatory papules and pustules on a red base; first-line options are topical metronidazole, azelaic acid and ivermectin.
- Phymatous subtype: thickened, bulbous skin with sebaceous hyperplasia, most often on the nose as rhinophyma; oral isotretinoin is used selectively and surgery or laser reduces established bulk.
- Ocular subtype: blepharitis, conjunctival injection and dry eye, with keratitis as the complication that threatens vision and needs ophthalmology review.
- Oral doxycycline: 40 mg modified-release doxycycline works as an anti-inflammatory at sub-antimicrobial dose and is used in papulopustular disease.
- Avoid: topical corticosteroids, which worsen rosacea and can cause steroid-induced rosacea, along with triggers such as heat, alcohol and spicy food.
Subtype-based treatment at a glance
Rosacea treatment is matched to the dominant subtype rather than given as one regimen to every patient. The table lists the usual first choices, and most patients have a mixture of subtypes.
| Subtype | Dominant feature | Usual first-line therapy |
|---|---|---|
| Erythematotelangiectatic | Flushing, persistent erythema, visible vessels | Brimonidine or oxymetazoline gel; pulsed-dye laser or intense pulsed light |
| Papulopustular | Papules and pustules on a red base | Topical metronidazole, azelaic acid or ivermectin; low-dose doxycycline |
| Phymatous | Thick skin with sebaceous hyperplasia | Oral isotretinoin in selected cases; surgery or laser for bulk |
| Ocular | Blepharitis, dry eye, keratitis | Lid hygiene and artificial tears; ophthalmology review and oral doxycycline |
Mixed presentations are common, so a topical agent for papules is often paired with a vascular treatment for erythema. Rosacea is controlled rather than cured, and relapse after stopping treatment is expected.
Clinicians should record the dominant subtype at each visit, because the priority shifts as papules settle while erythema or phymatous change persists. Sun protection and trigger avoidance support every regimen, and patients should be told that the condition is chronic from the outset.
Where the exam tries to catch you
Rosacea questions test subtype recognition, the steroid trap and the drug used for each subtype.
- Trap: treating papulopustular rosacea with topical steroids because the lesions look like acne Correct: steroids worsen rosacea, so use metronidazole, azelaic acid or ivermectin instead.
- Trap: choosing a full antimicrobial dose of doxycycline for routine papulopustular disease Correct: the sub-antimicrobial 40 mg modified-release preparation controls inflammation without the antibiotic dose.
- Trap: classifying rosacea by flushing alone and ignoring the eyes Correct: ocular involvement needs review because keratitis can threaten vision.
- Trap: prescribing isotretinoin for every patient with rosacea Correct: it is reserved for severe or refractory papulopustular and phymatous disease, with monitoring.
Frequently asked questions
Which rosacea subtype is treated with pulsed-dye laser or intense pulsed light?
Erythematotelangiectatic rosacea is the subtype treated with pulsed-dye laser or intense pulsed light, which target visible vessels and persistent redness. Topical or oral therapy is usually continued alongside these procedures. Papulopustular disease is not the usual target for vascular lasers.
What is the role of low-dose doxycycline in papulopustular rosacea?
Doxycycline 40 mg modified-release is used at sub-antimicrobial dose in papulopustular rosacea. It reduces inflammation through effects on matrix metalloproteinases rather than by killing bacteria. It is generally well tolerated over several months of use.
Why are topical corticosteroids avoided in rosacea?
Topical corticosteroids can worsen rosacea and cause steroid-induced rosacea, with persistent erythema, papules and pustules. Rosacea is often misdiagnosed as acne or eczema, which leads to steroid misuse. This misdiagnosis is a classic exam trap.
Which ocular complication of rosacea needs urgent ophthalmology review?
Keratitis is the ocular complication of rosacea that needs urgent ophthalmology review, because corneal involvement can threaten vision. Blepharitis and conjunctivitis are more common and are managed with lid hygiene, artificial tears and oral doxycycline. Eye symptoms can precede the skin disease.
Which drug is used for phymatous rosacea?
Oral isotretinoin is used in selected cases of phymatous rosacea, particularly when marked sebaceous hyperplasia is present. Established rhinophyma is usually reduced surgically or with laser. Isotretinoin requires monitoring and strict pregnancy precautions.